The correlation between serum pollen specific IgE and clinical indices before and after omalizumab treatment in patients with severe seasonal allergic rhinitis

The correlation between serum pollen specific IgE and clinical indices before and after omalizumab treatment in patients with severe seasonal allergic rhinitis - The correlation between pollen specific IgE and clinical indices before and after omalizumab treatment in seasonal allergic rhinitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047021

Enrollment

Registered

2022-02-28

Start date

2022-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seasonal allergic rhinitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)patients with severe seasonal allergic rhinitis (2)patients who take anti-histamine (3)patients who are equal or older than 12 years old (4)patients who give informed consent

Exclusion criteria

Exclusion criteria: (1)patients who take omalizumab (2)patients who are pregnant or breast feeding

Design outcomes

Primary

Measure	Time frame
To assess the correlation between serum pollen specific IgE and treatment responsiveness of omalizumab	—

Countries

Japan

Contacts

Public Contacttomoko tajiri

Nagoya City University Graduate School of Medical Sciences Respiratory Medicine, Allergy and Clinical Immunology

tomokot@med.nagoya-cu.ac.jp+81528587215

Outcome results